Pliant Therapeutics, Inc.
PLRX· Nasdaq
Released Aug 11, 2026, after the close
10-Q filed Aug 11, 2026, 42 days after period end · 0001746473-26-000113
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Revenue | — | — | $0.00 | $248.00K |
| Net Income | -$22.37M | -$43.30M | -$55.85M | -$41.19M |
| EPS Diluted |
Pliant Therapeutics, Inc. · CIK 1746473 · Engraved from SEC EDGAR
| -$0.36 |
| -$0.71 |
| -$0.92 |
| -$0.70 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.